Ítem


Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models

Spandidos Publications

Data: 1 juny 2018
Accés al document: http://hdl.handle.net/2072/312153
Editor: Spandidos Publications
Drets: Tots els drets reservats
Matèria: Recte -- Càncer
Rectum -- Cancer
Marcadors tumorals
Tumor markers
Títol: Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models
Tipus: info:eu-repo/semantics/article
Repositori: Recercat

Matèries

Autors